Home > Resources > Whitepapers > Vendor Partnering in a Bioprocess Manufacturing and Supply Chain Ecosystem

Industrial Impact

Vendor Partnering in a Bioprocess Manufacturing and Supply Chain Ecosystem

August 30, 2022

Supply constancy, cost, sterility – even a subset of
the factors that impact materials selection can be
daunting for biopharmaceutical companies embark.

Spotlight

Roslin BioCentre

Situated on the South side of Edinburgh, Roslin BioCentre is a 'Centre of Excellence' for Life Sciences and the location of choice for a wide variety of Life Science Companies. Roslin prides itself on an unrivalled ability to cater for the needs of both office and lab-based organisations by providing flexible, affordable accommodation for a range of companies located on site.

OTHER WHITEPAPERS

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Multi-Specific Monoclonal Antibodies

whitePaper | February 22, 2023

The reason for the rapid expansion and development of the therapeutic antibody sector is the capacity of monoclonal antibodies to precisely bind a target antigen and neutralise or promote its activity. The efficacy and safety.

How Can Biotechnology and Pharmaceutical Industries Better Weather This New Economy?

whitePaper | October 10, 2022

Biotechnology and pharmaceutical industries continue to experience increased pressure on financial performance due to several factors.

Pioneering Cell and Gene Therapy Solutions From Discovery to the Clinic

whitePaper | April 14, 2020

Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you. As a full-solution ancillary reagent and services provider, we will stand by you, providing flexible and pioneering tools to simplify your workflow. From CAR T cells to pluripotent stem cells, let us help you get your therapy to the patients that need it

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Vaccine and Biologics Development in an Emerging Post Pandemic Landscape

whitePaper | September 20, 2022

It is clear within the global health science industry that analytical biosafety testing and advances in developing scientific technologies will play an important role in drug development’s response to the next pandemic.